News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
183,649 Results
Type
Article (7579)
Company Profile (82)
Press Release (175998)
Multimedia
Podcasts (90)
Webinars (16)
Section
Business (61292)
Career Advice (385)
Deals (9815)
Drug Delivery (40)
Drug Development (32065)
Employer Resources (76)
FDA (2829)
Job Trends (4279)
News (96530)
Policy (6789)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (274)
Accelerated approval (20)
ADA (11)
Adcomms (5)
Allergies (62)
Alliances (12188)
ALS (81)
Alzheimer's disease (556)
Antibody-drug conjugate (ADC) (265)
Approvals (3107)
Artificial intelligence (255)
ASCO (107)
Autoimmune disease (159)
Automation (16)
Bankruptcy (65)
Best Places to Work (3218)
BIO (35)
BIOSECURE Act (16)
Biosimilars (157)
BioSpace Insights (55)
Biotechnology (51)
Bladder cancer (54)
Brain cancer (25)
Breast cancer (202)
Cancer (2131)
Cardiovascular disease (134)
Career advice (371)
Career pathing (40)
CAR-T (125)
CDC (15)
Celiac Disease (1)
Cell therapy (303)
Cervical cancer (16)
Clinical research (29531)
Collaboration (852)
Commercialization (3)
Company closure (1)
Compensation (921)
Complete response letters (44)
COVID-19 (720)
CRISPR (35)
C-suite (616)
Cystic fibrosis (48)
Data (3353)
Decentralized trials (1)
Denatured (14)
Depression (82)
Dermatology (33)
Diabetes (166)
Diagnostics (689)
Digital health (9)
Diversity (7)
Diversity, equity & inclusion (19)
Drug discovery (108)
Drug pricing (62)
Drug shortages (4)
Duchenne muscular dystrophy (95)
Earnings (25492)
Editorial (51)
Employer branding (10)
Employer resources (67)
Events (37417)
Executive appointments (539)
FDA (4269)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (3)
Frontotemporal dementia (9)
Funding (606)
Gene editing (69)
Generative AI (25)
Gene therapy (202)
GLP-1 (368)
Government (867)
Grass and pollen (1)
Guidances (147)
Healthcare (2430)
Hematology (72)
HIV (43)
Huntington's disease (17)
IgA nephropathy (30)
Immunology and inflammation (111)
Immuno-oncology (49)
Indications (98)
Infectious disease (821)
Inflammatory bowel disease (89)
Inflation Reduction Act (8)
Influenza (29)
Intellectual property (116)
Interviews (69)
IPO (5845)
IRA (18)
Job creations (1031)
Job search strategy (271)
JPM (35)
Kidney cancer (15)
Labor market (104)
Layoffs (203)
Leadership (40)
Legal (922)
Licensing (2)
Liver cancer (34)
Longevity (6)
Lung cancer (373)
Lymphoma (173)
Machine learning (24)
Management (25)
Manufacturing (462)
Marketing (7)
MASH (143)
Medical device (460)
Medtech (468)
Mergers & acquisitions (4589)
Metabolic disorders (596)
mRNA (71)
Multiple sclerosis (90)
NASH (8)
Neurodegenerative disease (152)
Neuropsychiatric disorders (52)
Neuroscience (1208)
NextGen: Class of 2026 (988)
Non-profit (250)
Now hiring (70)
Obesity (269)
Opinion (132)
Ovarian cancer (73)
Pain (72)
Pancreatic cancer (90)
Parkinson's disease (108)
Partnered (4)
Patents (203)
Patient recruitment (330)
Peanut (22)
People (18448)
Pharmaceutical (27)
Pharmacy benefit managers (5)
Phase 1 (8899)
Phase 2 (13549)
Phase 3 (9968)
Pipeline (4289)
Policy (155)
Postmarket research (505)
Preclinical (3336)
Press Release (19)
Prostate cancer (96)
Psychedelics (26)
Radiopharmaceuticals (156)
Rare diseases (444)
Real estate (1182)
Recruiting (35)
Regulatory (7135)
Reports (35)
Research institute (307)
Resumes & cover letters (45)
RNA editing (6)
RSV (33)
Schizophrenia (135)
Series A (111)
Series B (77)
Service/supplier (2)
Sickle cell disease (39)
Special edition (27)
Spinal muscular atrophy (56)
Sponsored (7)
Startups (976)
State (1)
Stomach cancer (3)
Supply chain (33)
Tariffs (48)
The Weekly (75)
Vaccines (293)
Venture capital (69)
Weight loss (124)
Women's health (31)
Worklife (18)
Date
Today (30)
Last 7 days (192)
Last 30 days (968)
Last 365 days (11238)
2026 (7210)
2025 (11097)
2024 (12499)
2023 (14258)
2022 (16119)
2021 (17786)
2020 (15165)
2019 (9955)
2018 (7096)
2017 (8901)
2016 (7259)
2015 (9250)
2014 (7024)
2013 (5055)
2012 (4827)
2011 (4766)
2010 (4692)
Location
Africa (175)
Alabama (23)
Arizona (46)
Arkansas (2)
Asia (14476)
Australia (1635)
California (5581)
Canada (1089)
China (1052)
Colorado (212)
Connecticut (267)
Delaware (255)
Europe (26608)
Florida (820)
Georgia (160)
Idaho (3)
Illinois (313)
India (39)
Indiana (187)
Iowa (15)
Japan (264)
Kansas (82)
Kentucky (12)
Louisiana (4)
Maine (2)
Maryland (551)
Massachusetts (4455)
Michigan (54)
Minnesota (177)
Mississippi (2)
Missouri (35)
Montana (2)
Nebraska (6)
Nevada (23)
New Hampshire (8)
New Jersey (1771)
New Mexico (7)
New York (1727)
North Carolina (709)
Northern California (3038)
Ohio (140)
Oklahoma (10)
Oregon (13)
Pennsylvania (981)
Puerto Rico (15)
Rhode Island (11)
South America (211)
South Carolina (6)
Southern California (2169)
Tennessee (28)
Texas (624)
United States (19247)
Utah (112)
Virginia (124)
Washington D.C. (24)
Washington State (358)
West Virginia (1)
Wisconsin (23)
183,649 Results for "kbi biopharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
KBI Biopharma, Inc. Announces Collaboration with Infinimmune Inc. to Support Antibody Manufacturing
September 9, 2025
·
3 min read
Business
KBI Biopharma Appoints Jean-Baptiste Agnus as Chief Business Officer
KBI Biopharma, Inc. today announced the appointment of Jean-Baptiste (JB) Agnus as Chief Business Officer, solidifying KBI’s Executive Team.
April 15, 2024
·
3 min read
Career Advice
The top 12 companies hiring in biopharma now
Looking for a biopharma job? Check out the
BioSpace
list of 12 top companies hiring life sciences professionals like you.
August 6, 2026
·
1 min read
·
Angela Gabriel
Job Trends
Report: Biopharma Job Market Report Q2 2026
Gain the latest insights into the biopharma hiring landscape with BioSpace’s Biopharma Job Market Report Q2 2026. Explore the trends shaping talent acquisition, from rising job postings and sustained R&D hiring to the market activity signaling stronger hiring demand ahead.
July 13, 2026
·
1 min read
·
BioSpace Insights
Job Trends
July’s biopharma layoffs affect 466 employees, a 94% year-over-year drop
Last month, biopharmas cutting or planning to cut their workforces included Amgen, GSK and Novartis, with Novartis’ layoffs affecting the most people.
August 13, 2026
·
3 min read
·
Angela Gabriel
Business
KBI Biopharma Strengthens Quality and Regulatory Affairs Expertise with Appointment of Chief Quality Officer
KBI Biopharma, Inc., a JSR Life Sciences company and cGMP contract development and manufacturing organization, announced the appointment of Peter Carbone as the new Chief Quality Officer, strengthening KBI’s expertise in Quality and Regulatory Affairs.
April 1, 2024
·
3 min read
SUPPORTED BY AMPLITY
Webinar: From Clinical to Commercial: Talent Strategies for Biopharma Growth
This webinar provides an assessment of recent job market activity across biopharma and explores how companies approaching commercial readiness or building out sales and marketing teams can navigate today’s hiring trends.
July 22, 2026
·
1 min read
·
BioSpace Insights
Layoffs
Not-so-special delivery: When biopharmas fumble layoff news
So far in 2026, over 50 biopharmas have cut or plan to cut their workforces. If they didn’t take a careful, thoughtful approach to telling people they were being laid off, they likely left a negative impression on employees, based on stories shared with
BioSpace
.
July 30, 2026
·
3 min read
·
Angela Gabriel
Artificial intelligence
Biopharma R&D needs ‘structural redesign’ to maximize AI impact: report
Biopharma companies won’t fully capture the benefits of AI unless they reorganize their R&D units, according to McKinsey.
July 9, 2026
·
2 min read
·
Nick Paul Taylor
Job Trends
Biopharma layoffs must double in H2 for 2026 to match 2025 cuts
With fewer biopharmas making or planning workforce reductions so far year over year, layoff round size and M&A impact on headcounts will likely shape the number of employees who are ultimately on the chopping block.
July 23, 2026
·
4 min read
·
Angela Gabriel
1 of 18,365
Next
